跳至主要内容
临床试验/IRCT2017061034432N1
IRCT2017061034432N1尚未招募2 期

Comparative study of captopril, spinenolactone and carvedilol on endothelial function in women with breast cancer under chemotherapy

Vice-chancellor of research, Isfahan University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • Women with breast cancer chemotherapy candidate; aged 30-70 years; having sinus rhythm; having echocardiography for LVEF (equal to or greater than 50%)
  • Exclusion criteria:
  • LVEF Less than 50%; previous myocardial infarction or known coronary artery disease; significant valvulopathy or cardiomyopathy (GFR <30 mm / min / 1.73m2); patients treated with ACEI, beta blocker, or ARB; drug sensitivity to ACEI, beta blocker, ARB; (SBP <90 mmHg and HR <60 beat / min); patients who currently have an AF rhythm and need treatment with class I antiarrhythmic drugs; pregnancy; dissatisfaction with participation in the research project; death

排除标准

  • 未提供

研究者

发起方
Vice-chancellor of research, Isfahan University of Medical Sciences

相似试验